首页 | 本学科首页   官方微博 | 高级检索  
检索        


Importance of factors H and I for the adherence of C3b-coated erythrocytes to cells
Authors:O Scheiner  T F Schulz  H U Schmid  J D Lambris  J Alsenz  M P Dierich
Institution:Institute of Medical Microbiology, Johannes Gutenberg University, Mainz, Federal Republic of Germany
Abstract:The role of cell membrane-associated human factor H for the binding of cell-bound C3b to complement receptor-carrying (CR+) cells was investigated. Pretreatment of CR+ cells with antibodies to factor H inhibited the adherence of C3b-coated red cells to human tonsil lymphocytes (TL) and peripheral blood monocytes (M phi). The C3b receptor reactivity of human polymorphonuclear leucocytes (PMN) was not influenced and the one of Raji lymphoblastoid cells only slightly influenced; iC3b and C3d receptor reactivity was in no case affected. When diisopropylfluorophosphate (DFP) in a concentration of 0.1 mM was present during pretreatment of the CR+ cells with anti H, the antibodies gained the capacity to inhibit the adherence of C3b-coated erythrocytes to Raji cells; this effect was dose-dependent with respect to DFP. In contrast, there was no influence of DFP on the inhibition pattern of anti H in the case of TL and M phi. The adherence of C3b-coated erythrocytes to PMN remained unaffected by anti-H antibodies in the presence of DFP. Polyclonal as well as monoclonal antibodies directed against human factor I inhibited the binding of C3b cells to Raji cells but not to TL. Additionally, when anti I and anti H antibodies were both present, C3b receptor reactivity of Raji cells was inhibited to a larger extent than with either antibody alone; again, TL remained unaffected. Results obtained by washing the Raji cells before and after treatment with anti H and anti I suggest that the respective antibodies act on factor H primarily on the level of the cell membrane and on factor I in the fluid phase.
Keywords:first  second  third  fourth  fifth component of the complement system  b fragment of C3    Cab treated with factors H and I  d fragment of C3  complement receptor carrying  complement receptor negative  diisopropylfluorophosphate  SRBC coated with antibody C1  C4  oxydized C2 and C3  EAC14°23b treated with factors H and I  EAC14°23bi treated with trypsin  glycoprotein  factor H of the alternative pathway of complement activation  factor I of the alternative pathway of complement activation  minimum essential medium  molecular weight  human peripheral blood monocytes  phosphate-buffered isotonic saline  polymorphonuclear leucocytes  poke wheat mitogen  PMW-stimulated TL  sheep red blood cells  human tonsil lymphocytes  veronal-buffered isotonic saline containing 20mM EDTA
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号